Castle Biosciences, Inc.
CSTL
$24.06
$0.502.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 275.93M | 275.15M | 293.13M | 279.79M | 259.69M |
| Total Receivables | 53.31M | 56.95M | 51.22M | 50.26M | 45.99M |
| Inventory | 8.37M | 6.85M | 8.14M | 6.57M | 8.01M |
| Prepaid Expenses | 11.06M | 10.44M | 7.67M | 8.15M | 6.72M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 348.67M | 349.39M | 360.15M | 344.77M | 320.41M |
|
|
|||||
| Total Current Assets | 348.67M | 349.39M | 360.15M | 344.77M | 320.41M |
| Net Property, Plant & Equipment | 89.56M | 66.59M | 62.71M | 56.29M | 50.26M |
| Long-term Investments | 10.69M | 10.69M | 10.69M | 10.69M | 10.69M |
| Goodwill | 10.69M | 10.69M | 10.69M | 10.69M | 10.69M |
| Total Other Intangibles | 93.43M | 67.21M | 95.54M | 99.88M | 102.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.37M | 2.27M | 2.15M | 2.94M | 3.81M |
| Total Assets | 544.73M | 501.72M | 531.24M | 514.57M | 487.31M |
|
|
|||||
| Total Accounts Payable | 13.18M | 8.50M | 6.90M | 6.81M | 9.54M |
| Total Accrued Expenses | 31.13M | 23.77M | 38.70M | 35.10M | 27.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.52M | 2.55M | 2.04M | 1.75M | 1.23M |
| Total Finance Division Other Current Liabilities | 3.06M | 2.45M | 1.75M | 640.00K | 955.00K |
| Total Other Current Liabilities | 3.06M | 2.45M | 1.75M | 640.00K | 955.00K |
| Total Current Liabilities | 50.89M | 37.27M | 49.39M | 44.30M | 39.45M |
|
|
|||||
| Total Current Liabilities | 50.89M | 37.27M | 49.39M | 44.30M | 39.45M |
| Long-Term Debt | 8.10M | 8.92M | 9.75M | 10.02M | 10.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.74M | 14.38M | 14.66M | 14.98M | 13.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.63M | 837.00K | 1.61M | 4.22M | -- |
| Total Liabilities | 89.35M | 61.41M | 75.40M | 73.51M | 63.42M |
|
|
|||||
| Common Stock & APIC | 676.79M | 666.15M | 655.73M | 650.30M | 636.05M |
| Retained Earnings | -221.45M | -225.97M | -200.13M | -209.72M | -211.99M |
| Treasury Stock & Other | 39.00K | 131.00K | 230.00K | 473.00K | -172.00K |
| Total Common Equity | 455.38M | 440.31M | 455.84M | 441.06M | 423.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 455.38M | 440.31M | 455.84M | 441.06M | 423.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 455.38M | 440.31M | 455.84M | 441.06M | 423.89M |
|
|
|||||